Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rabeprazole-based quadruple therapy dose and antibiotic comparison for Helicobacter pylori-associated duodenal ulcer
ChiCTR1800014832Phase 4Completed
- Sponsor
- First Affiliated Hospital of Nanchang University
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of rabeprazole, bismuth subsalicylate, amoxicillin, clarithromycin and tetracycline in Helicobacter pylori infection and duodenal ulcer (4 arms), sponsored by First Affiliated Hospital of Nanchang University. Primary endpoint: H. pylori eradication rate. Started Mar 2013; status: completed.
02
Drugs
rabeprazolebismuth subsalicylateamoxicillinclarithromycintetracycline
03
Conditions
Helicobacter pylori infectionduodenal ulcer
Beyond the preview
Go deeper on ChiCTR1800014832.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800014832.